skip to main content


What We Do

We are a global bioscience company dedicated to healthy aging. Our team, which includes world-renowned scientists, is pioneering research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. We are the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen®. Nicotinamide riboside and other NAD+ precursors are protected by our patent portfolio.


We deliver Niagen® as the sole active ingredient in our consumer product Tru Niagen®.

We also have a business unit focused on natural product fine chemicals (known as “phytochemicals”).

ChromaDex, Inc. is listed on NASDAQ, stock name CDXC.


ChromaDex scientists partner with leading universities and research institutions worldwide to uncover the full potential of nicotinamide adenine dinucleotide (“NAD”) and to identify and develop novel, science-based ingredients.

A2LA Accredited Symbol 5211.01   A2LA accredited symbol 5211.02

Our Culture

At ChromaDex, we foster a culture of empowerment, ownership and trust. Our incredible employees achieve success by acting with integrity, transparency and excitement. We firmly believe that through innovation, science and collaboration between our teams, we can aim to improve global health and ultimately impact the quality of all human lives. 

We are constantly looking for new team members who share our passion for our mission and want to be part of our story.